Active
Overview
- Legal name
- CROSSJECT SA
- Registered location
- DIJON, FRA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Sep 16, 2025
Read company summary
CROSSJECT SA is associated with UEI NLXZHCL3NLL3 and CAGE FBEF0 in public federal records. AcornBids currently links 1 prime award totaling $104.2M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists DIJON, FRA.
At a glance
Lifetime prime obligations$104.2M
Prime awards1
Awards with future end dates1
Top-agency concentration100.0%
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- CROSSJECT SA
- UEI
- NLXZHCL3NLL3
- CAGE
- FBEF0
- Registered address
- 6 RUE PAULINE KERGOMARD, DIJON, 21000, FRA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Oct 9, 2025
- Initial registration
- May 14, 2019
- Entity start
- Aug 8, 2001
- SAM updated
- Oct 9, 2025
- Registration expires
- Oct 9, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- FRA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75A50122C00031ADVANCED RESEARCH AND DEVELOPMENT AND DELIVERY OF ADULT AND PEDIATRIC MIDAZOLAM AUTOINJECTORS THAT HAVE RECEIVED EMERGENCY USE AUTHORIZATION (EUA) OR FDA APPROVAL FOR THE… | Department of Health and Human Services | $104.2M | Jun 22, 2022 | Jun 21, 2030 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Oct 9, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | May 14, 2019 |
| Entity start | Aug 8, 2001 |
| Industry | Reported size status |
|---|---|
| 325411 — Medicinal and Botanical Manufacturing | Not reported |
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 325414 — Biological Product (except Diagnostic) Manufacturing | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| PATRICK ALEXANDRE | Government business | Contact method not published | SAM registration | Not available |
| PATRICK ALEXANDRE | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325411 — Medicinal and Botanical Manufacturing
- 325412 — Pharmaceutical Preparation Manufacturing
- 325414 — Biological Product (except Diagnostic) Manufacturing
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
49 awards
26 awards
25 awards
20 awards
18 awards
16 awards
15 awards
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit